货号:A551904
同义名:
8-溴腺苷-3',5'-环单磷酸钠
/ 8-Bromo-cAMP sodium salt; 8-Br-Camp sodium salt
8-Bromoadenosine 3',5'-cyclic monophosphate sodium salt是一种可透过细胞膜的 cAMP 类似物,激活环磷酸腺苷依赖的蛋白激酶,Ka 值为 0.05 μM,是一种 PKA 激活剂。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | PKA ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Daphnetin |
+
PKA, IC50: 9.33 μM |
EGFR,PKC | 95% | ||||||||||||||||
| AT13148 |
++++
PKA, IC50: 3 nM |
95% | |||||||||||||||||
| A-674563 HCl |
+++
PKA, Ki: 16 nM |
99% | |||||||||||||||||
| H-89 2HCl |
++
PKA, Ki: 48 nM |
99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | The cAMP/PKA signaling pathway regulates a wide range of cellular processes. 8-Bromo-cAMP is an activator of PKA with a Ka value of 0.05 μM[3]. Treatment of 0.1 and 0.5 mM 8-Bromo-cAMP significantly increased the number of NANOG positive ES cell-like colonies in human fibroblast cells compared to the negative control. The combination of 0.1 mM 8-Bromo-cAMP and 0.5 mM VPA inhibited the proliferation rates at day 3, 4 and 5 in HFF1 cells. The same co-treatment of 8-Bromo-cAMP and VPA in HFF1 cells also induced the upregulation of cytokine-related and inflammatory pathways at day 1, and down-regulated the p53, cell cycle and RB pathways[4]. In BEAS-2B cells, pretreatment of 100 μM 8-Bromo-cAMP for one hour significantly reduced HDE-induced release of IL-6 and IL-8 compared to cells only received 24-h treatment of 5% HDE with presence of 100 μM 8-Br-cAMP. Also in BEAS-2B cells, HDE (5%) significantly promoted the maximal PKC-ε activity at 6h, but pretreatment with 100 μM 8-Bromo-cAMP for hour blocked HDE-stimulated PKC-ε. The 1-h treatment with 8-Bromo-cAMP (0.1–10 μM) also significantly increased PKA activity in a dose-dependent manner[5]. In ddY mice, pretreatment with 8-Br-cAMP (i.p., 10 mg/kg) prior to LPS injection significantly inhibited LPS-induced dye leakage in the skin and the increase of serum TNF-α level[6]. |
| 作用机制 | 8-Bromo-cAMP is a brominated derivative of cAMP that functions as a cell-permeable analog of cAMP to activate cAMP-dependent protein kinase (PKA)[5]. |
| Concentration | Treated Time | Description | References | |
| Nonpregnant uterine artery endothelial cells (NP-UAECs) | 1 µM and 1 mM | 0 to 60 minutes or 12 hours | 8-Br-cAMP did not significantly increase Cx43 S365 signal in NP-UAECs. | Hypertension. 2017 Aug;70(2):401-411. |
| Pregnant uterine artery endothelial cells (P-UAECs) | 1 µM and 1 mM | 0 to 60 minutes or 12 hours | 8-Br-cAMP significantly increased nonphosphorylated Cx43 S365 signal and total Cx43 phosphorylation, but not S368 phosphorylation. | Hypertension. 2017 Aug;70(2):401-411. |
| Human umbilical vein endothelial cells (HUVECs) | 200 µM | 1 hour | Mimicked the effect of caffeine in inducing AMPK phosphorylation and enhanced endothelial cell migration | Acta Pharmacol Sin. 2021 Dec;42(12):2033-2045. |
| Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) | 0.5 mM | 21 days | 8-Br-cAMP upregulated vimentin and CD13 and downregulated CK and CD9, promoting the differentiation of WJ-MSCs into ESC-like cells. | Stem Cell Res Ther. 2017 Nov 2;8(1):246. |
| Human endometrial stromal (hES) cells | 0.5 mM | 2-4 days | Investigate the differential regulation of mTORC1 and mTORC2 during 8-Br-cAMP-induced decidualization. Results showed increased mTORC1 activity and decreased mTORC2 activity, leading to reduced Akt phosphorylation and activation of FOXO1, promoting the expression of decidualization markers PRL and IGFBP1. | Exp Mol Med. 2018 Oct 30;50(10):1-11. |
| Human esophageal cancer cell line Eca-109 | 20 µM | 24 hours | To investigate the effects of 8-Br-cAMP on differentiation and apoptosis of Eca-109 cells. Results showed that the signals of wt p53 and iNOS were markedly stronger, while the signals of c-myc and EGFR were obviously weaker in E1 group (24-hour treatment). | World J Gastroenterol. 2005 Nov 7;11(41):6538-42. |
| JEG-3 cells | 250 µM | 36 hours | Induced trophoblastic differentiation and upregulated LGALS16 and CGB3/5 gene expression | Biomolecules. 2021 Dec 20;11(12):1909. |
| Human esophageal cancer cell line Eca-109 | 20 µM | 48 hours | To investigate the effects of 8-Br-cAMP on differentiation and apoptosis of Eca-109 cells. Results showed that the signals of wt p53, iNOS, p38 kinase, and caspase-3 were significantly stronger, whereas the signals of bcl-2, c-myc, and Fas/FasL were markedly weaker in E2 group (48-hour treatment). | World J Gastroenterol. 2005 Nov 7;11(41):6538-42. |
| BeWo cells | 250 µM | 48 hours | Induced trophoblastic differentiation and upregulated LGALS16 and CGB3/5 gene expression | Biomolecules. 2021 Dec 20;11(12):1909. |
| Rat heart cells | 10 µM | 5 minutes | To evaluate the protective effects of 8-Br on the heart, results showed that 8-Br significantly reduced ventricular arrhythmias, improved hemodynamic function, and reduced infarct size | Cells. 2021 May 17;10(5):1223. |
| Differentiated HL-60 neutrophil-like cells (dHL-60) | 10 µM | 7 hours | Inhibited NETosis induced by PMA or rabbit anti-B19V-VP1u IgG | Int J Mol Sci. 2024 Sep 13;25(18):9917. |
| Canine ventricular myocytes | 250 µM | To investigate the effect of 8-Br-cAMP on IKr and IKs, results showed that 8-Br-cAMP significantly increased the current amplitudes of IKr and IKs | Br J Pharmacol. 2011 Feb;162(4):890-6. | |
| Dose | Cat: 0.35 mg/kg - 1 mg/kg[3] (intra-arterial injection) Mice: 330 mg/kg[4] (i.p.), 10 mg/kg[5] (i.p.) |
| Administration | Intra-arterial injection, i.p. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.33mL 0.47mL 0.23mL |
11.63mL 2.33mL 1.16mL |
23.25mL 4.65mL 2.33mL |
|
| CAS号 | 76939-46-3 |
| 分子式 | C10H10BrN5NaO6P |
| 分子量 | 430.08 |
| SMILES Code | NC1=C(N=C(Br)N2[C@@H]3O[C@@](COP(O4)([O-])=O)([H])[C@]4([H])[C@H]3O)C2=NC=N1.[Na+] |
| MDL No. | MFCD00005844 |
| 别名 | 8-溴腺苷-3',5'-环单磷酸钠 ;8-Bromo-cAMP sodium salt; 8-Br-Camp sodium salt; 8 Br cAMP Na; 8-Br-cAMP sodium; 8-Bromoadenosine 3',5'-cyclic monophosphate; 8-bromo-Cyclic AMP (sodium salt); 8-Bromo-cAMP |
| 运输 | 蓝冰 |
| InChI Key | DMRMZQATXPQOTP-GWTDSMLYSA-M |
| Pubchem ID | 23702958 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 120 mg/mL(279.02 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 100 mg/mL(232.51 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1